These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines. Yi JS; Perla S; Enyenihi L; Bennett AM JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584792 [TBL] [Abstract][Full Text] [Related]
5. Phosphoproteomics-mediated identification of Fer kinase as a target of mutant Shp2 in Noonan and LEOPARD syndrome. Paardekooper Overman J; Preisinger C; Prummel K; Bonetti M; Giansanti P; Heck A; den Hertog J PLoS One; 2014; 9(9):e106682. PubMed ID: 25184253 [TBL] [Abstract][Full Text] [Related]
6. Low-dose dasatinib rescues cardiac function in Noonan syndrome. Yi JS; Huang Y; Kwaczala AT; Kuo IY; Ehrlich BE; Campbell SG; Giordano FJ; Bennett AM JCI Insight; 2016 Dec; 1(20):e90220. PubMed ID: 27942593 [TBL] [Abstract][Full Text] [Related]
7. Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects. Jopling C; van Geemen D; den Hertog J PLoS Genet; 2007 Dec; 3(12):e225. PubMed ID: 18159945 [TBL] [Abstract][Full Text] [Related]
8. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner. Zheng H; Yu WM; Waclaw RR; Kontaridis MI; Neel BG; Qu CK Sci Signal; 2018 Mar; 11(522):. PubMed ID: 29559584 [TBL] [Abstract][Full Text] [Related]
9. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. Kontaridis MI; Swanson KD; David FS; Barford D; Neel BG J Biol Chem; 2006 Mar; 281(10):6785-92. PubMed ID: 16377799 [TBL] [Abstract][Full Text] [Related]
10. Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling. Noda S; Takahashi A; Hayashi T; Tanuma S; Hatakeyama M Biochem Biophys Res Commun; 2016 Jan; 469(4):1133-9. PubMed ID: 26742426 [TBL] [Abstract][Full Text] [Related]
11. Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11). Qiu W; Wang X; Romanov V; Hutchinson A; Lin A; Ruzanov M; Battaile KP; Pai EF; Neel BG; Chirgadze NY BMC Struct Biol; 2014 Mar; 14():10. PubMed ID: 24628801 [TBL] [Abstract][Full Text] [Related]
12. PTPN11-associated mutations in the heart: has LEOPARD changed Its RASpots? Lauriol J; Kontaridis MI Trends Cardiovasc Med; 2011 May; 21(4):97-104. PubMed ID: 22681964 [TBL] [Abstract][Full Text] [Related]
13. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. Marin TM; Keith K; Davies B; Conner DA; Guha P; Kalaitzidis D; Wu X; Lauriol J; Wang B; Bauer M; Bronson R; Franchini KG; Neel BG; Kontaridis MI J Clin Invest; 2011 Mar; 121(3):1026-43. PubMed ID: 21339643 [TBL] [Abstract][Full Text] [Related]
15. Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase. Miura K; Wakayama Y; Tanino M; Orba Y; Sawa H; Hatakeyama M; Tanaka S; Sabe H; Mochizuki N Oncogene; 2013 Nov; 32(45):5292-301. PubMed ID: 23318428 [TBL] [Abstract][Full Text] [Related]
16. Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis. Huang WQ; Lin Q; Zhuang X; Cai LL; Ruan RS; Lu ZX; Tzeng CM Curr Cancer Drug Targets; 2014; 14(6):567-88. PubMed ID: 25039348 [TBL] [Abstract][Full Text] [Related]
17. Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Stewart RA; Sanda T; Widlund HR; Zhu S; Swanson KD; Hurley AD; Bentires-Alj M; Fisher DE; Kontaridis MI; Look AT; Neel BG Dev Cell; 2010 May; 18(5):750-62. PubMed ID: 20493809 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects. Solman M; Blokzijl-Franke S; Piques F; Yan C; Yang Q; Strullu M; Kamel SM; Ak P; Bakkers J; Langenau DM; Cavé H; den Hertog J Elife; 2022 May; 11():. PubMed ID: 35535491 [TBL] [Abstract][Full Text] [Related]
19. Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes. Martinelli S; Torreri P; Tinti M; Stella L; Bocchinfuso G; Flex E; Grottesi A; Ceccarini M; Palleschi A; Cesareni G; Castagnoli L; Petrucci TC; Gelb BD; Tartaglia M Hum Mol Genet; 2008 Jul; 17(13):2018-29. PubMed ID: 18372317 [TBL] [Abstract][Full Text] [Related]